Sale!

Scrub Typhus Tsutsugamushi Antibody IgM EIA Test

Original price was: $36.Current price is: $32.

-11%

The Scrub Typhus Tsutsugamushi Antibody IgM EIA Test is a specialized diagnostic tool that detects IgM antibodies against Orientia tsutsugamushi, the bacterium responsible for scrub typhus. This enzyme immunoassay provides early detection of acute infections, helping healthcare providers diagnose this potentially serious rickettsial disease. The test is particularly valuable for individuals experiencing fever, rash, and eschar formation after potential exposure in endemic areas. With results available the same day when samples are submitted by 9 am on Wednesday or Saturday, this test offers rapid diagnostic capabilities. The discounted price of $32 USD makes this essential testing accessible for timely medical intervention and appropriate treatment planning.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Scrub Typhus Tsutsugamushi Antibody IgM EIA Test

Comprehensive Diagnostic Testing for Scrub Typhus Infection

The Scrub Typhus Tsutsugamushi Antibody IgM EIA Test represents a critical advancement in the detection and diagnosis of scrub typhus, a potentially serious infectious disease caused by the bacterium Orientia tsutsugamushi. This sophisticated enzyme immunoassay (EIA) specifically targets IgM antibodies, which are the first immunoglobulins produced by the immune system in response to infection. Early detection through this precise testing methodology enables healthcare providers to initiate appropriate treatment promptly, significantly improving patient outcomes and reducing the risk of complications associated with untreated scrub typhus infections.

What Does This Test Measure and Detect?

The Scrub Typhus Tsutsugamushi Antibody IgM EIA Test specifically measures immunoglobulin M (IgM) antibodies directed against Orientia tsutsugamushi antigens. This sophisticated diagnostic approach offers several key advantages:

  • Early Infection Detection: IgM antibodies typically appear within 5-10 days after symptom onset, making this test invaluable for diagnosing acute scrub typhus infections
  • Specific Pathogen Identification: The test specifically targets Orientia tsutsugamushi, distinguishing it from other rickettsial diseases with similar clinical presentations
  • Quantitative Assessment: The EIA methodology provides measurable antibody levels, allowing for monitoring of disease progression and treatment response
  • High Sensitivity and Specificity: Advanced EIA technology ensures accurate results with minimal cross-reactivity to related pathogens

Who Should Consider This Test?

This specialized diagnostic test is recommended for individuals presenting with symptoms suggestive of scrub typhus, particularly those with recent travel history to endemic regions or potential exposure to mite habitats. Key indications include:

  • Fever of Unknown Origin: Patients experiencing persistent fever without clear etiology, especially following travel to rural or agricultural areas in Southeast Asia, the Pacific Islands, or other endemic regions
  • Characteristic Skin Manifestations: Individuals presenting with the classic eschar (a black scab-like lesion at the site of the mite bite) and/or maculopapular rash
  • Systemic Symptoms: Patients with headache, myalgia, cough, and lymphadenopathy in conjunction with fever
  • Recent Travel History: Individuals returning from areas where scrub typhus is endemic, particularly those engaged in outdoor activities, farming, or military operations
  • Occupational Exposure: Agricultural workers, forestry personnel, and military personnel with potential exposure to chigger mites in endemic regions

Clinical Benefits of Scrub Typhus Testing

Undergoing the Scrub Typhus Tsutsugamushi Antibody IgM EIA Test provides numerous clinical advantages for both patients and healthcare providers:

  • Early Intervention: Prompt diagnosis enables timely administration of appropriate antibiotics, significantly reducing the risk of severe complications including pneumonia, meningoencephalitis, and multi-organ failure
  • Differential Diagnosis: Helps distinguish scrub typhus from other febrile illnesses with similar presentations, such as dengue fever, malaria, and leptospirosis
  • Treatment Guidance: Confirms the diagnosis, allowing for targeted antimicrobial therapy with doxycycline, azithromycin, or chloramphenicol
  • Public Health Surveillance: Contributes to epidemiological data collection and outbreak monitoring in affected regions
  • Peace of Mind: Provides definitive answers for patients and families concerned about potential scrub typhus infection

Understanding Your Test Results

Interpreting your Scrub Typhus Tsutsugamushi Antibody IgM EIA Test results requires professional medical evaluation, but general guidance includes:

  • Positive Result: Indicates recent or current infection with Orientia tsutsugamushi. Your healthcare provider will recommend appropriate antibiotic treatment and may suggest follow-up testing to monitor response to therapy
  • Negative Result: Suggests no detectable IgM antibodies at the time of testing. However, if clinical suspicion remains high and symptoms persist, repeat testing in 7-14 days may be recommended as antibody levels can take time to develop
  • Equivocal/Borderline Result: May require retesting or additional diagnostic methods to confirm the diagnosis. Your physician will consider clinical presentation and exposure history when interpreting borderline results
  • Quantitative Values: The numerical values provided in the report help your healthcare provider assess the strength of the immune response and may guide treatment decisions

Test Pricing and Availability

Test Component Price (USD)
Scrub Typhus Tsutsugamushi Antibody IgM EIA Test $36
Discount Price $32

Nationwide Testing Availability

GGC DNA maintains comprehensive testing facilities across the United States, ensuring accessible scrub typhus diagnostic services in all major metropolitan areas. Our strategically located branches provide convenient sample collection and rapid result delivery. Key service locations include:

  • New York City and surrounding metropolitan area
  • Los Angeles and Southern California region
  • Chicago and Illinois testing centers
  • Houston and Texas medical facilities
  • Phoenix and Arizona diagnostic locations
  • Philadelphia and Pennsylvania testing sites
  • Additional locations throughout the continental United States

Convenient Testing Process

Our streamlined testing protocol ensures a seamless experience for patients and healthcare providers:

  • Sample Collection: Requires 3 mL (1 mL minimum) serum from SST tube
  • Shipping Instructions: Samples must be shipped refrigerated or frozen to maintain integrity
  • Turnaround Time: Samples submitted by 9 am on Wednesday or Saturday receive same-day results
  • No Special Preparation: Patients can undergo testing without fasting or other preparatory requirements
  • Professional Interpretation: All results include comprehensive analysis by our expert medical team

Schedule Your Scrub Typhus Test Today

Don’t let uncertainty about potential scrub typhus infection compromise your health. Early detection through our advanced Scrub Typhus Tsutsugamushi Antibody IgM EIA Test provides the clarity needed for appropriate medical management. Our discounted price of $32 USD makes this essential diagnostic tool accessible for timely intervention.

Take immediate action to protect your health:

Call +1(267) 388-9828 to book your test or schedule an appointment at any of our nationwide locations.

Our dedicated healthcare professionals are available to answer your questions, provide guidance on testing requirements, and ensure you receive the comprehensive care you deserve. Trust GGC DNA for accurate, reliable scrub typhus diagnostics and take the first step toward definitive answers and appropriate treatment today.